Dworzack 1988.
Methods | Double‐blind, ITT | |
Participants | Volunteers | |
Interventions | Ciprofloxacin 1 x 750 mg versus placebo | |
Outcomes | Eradication, resistance developed, adverse effects Follow‐up: 21 days | |
Notes | Main serogroups: B, Z | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Unclear risk | Unclear |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Double‐blind |
Incomplete outcome data (attrition bias) All outcomes | Low risk | ITT |
Selective reporting (reporting bias) | Low risk | No evidence |
Other bias | Low risk | No evidence |